PharmaTer

Specialty pharmaceutical company PharmaTher Holdings (OTCQB: PHRRF) has submitted a Fast Track Application to the Food and Drug Administration (FDA) for KETARX, a ketamine drug that may help treat levodopa-induced dyskinesia in Parkinson’s disease. Fast Track designation is for...

This article by Emily Jarvie was originally published on Psychedelic Spotlight, and appears here with permission. The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS. Psychedelic biotechnology company ...